AZD9496

AstraZeneca drops breast, prostate cancer programs in Q4 pipeline cull
Fierce Biotech
Thu, 02/11/21 - 10:34 am
AstraZeneca
oncology
AZD9496
breast cancer
imaradenant
prostate cancer